Grapheal is a spin-off from Neel Institute, at French Research Center CNRS in Grenoble. After 10 years of research and development on biomaterials fabrication and integration. Grapheal is born out of our will to improve chronic wounds medical care with a new generation of smart-bandages.
The core of our technology is linked to graphene physical and biochemical properties. We use it as a bioactive material, an electrical plateform for wound stimulation, and a biodetection plateform to monitor healing in real time. Our smart-bandages benefits to both patients and medical staff by combining an efficient and flexible dressing with a simple smartphone app to monitor, day after day, the wound healing progresses.
The core of our technology is linked to graphene physical and biochemical properties. We use it as a bioactive material, an electrical plateform for wound stimulation, and a biodetection plateform to monitor healing in real time. Our smart-bandages benefits to both patients and medical staff by combining an efficient and flexible dressing with a simple smartphone app to monitor, day after day, the wound healing progresses.
Location: France, Auvergne-Rhône-Alpes, Grenoble
Employees: 11-50
Total raised: $2.3M
Founded date: 2019
Investors 6
| Date | Name | Website |
| - | Novalis Bi... | noval.is |
| - | LG NOVA | lgnova.com |
| - | MassChalle... | masschalle... |
| 01.06.2021 | Creative D... | creativede... |
| - | Health Eng... | readysethe... |
| - | Linksium | linksium.f... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.02.2021 | - | $2.3M | Novalis Bi... |
Mentions in press and media 6
| Date | Title | Description |
| 26.02.2026 | Grapheal receives funding from the The European Innovation Council (EIC) – for its project PFAST | Grapheal is honored with the EIC accelerator award. This funding, provided by EIC, European Innovation Council, will enable our startup to scale its graphene biosensor... |
| 10.02.2021 | Grapheal Raises EUR 1.9M to in Funding | Grapheal, a Grenoble, France-based developer of graphene-based embedded biosensors for on-site diagnostics and remote patient monitoring, raised a total of EUR1.9m in equity and non-dilutive sources. This includes seed financing from Novali... |
| 09.02.2021 | Grapheal : Raises EUR1.9 Million to Advance Development of Embedded Biosensing Technology and Application in Digital COVID Testing and Wound Monitoring | Grapheal, a developer of graphene-based embedded biosensors for on-site diagnostics and remote patient monitoring, announced today that it has raised a total of EUR1.9 million in equity and non-dilutive sources, including seed financing fro... |
| 15.10.2020 | EIT Health names winning longevity innovations | EIT Health, together with seven global collaborators representing nearly 50 countries and territories, today announced the winners of the inaugural round of Healthy Longevity Catalyst Awards. The awards are part of the Healthy Longevity Glo... |
| 02.06.2020 | MassChallenge Switzerland Announces 5th Cohort | June 2, 2020 (Renens, Switzerland) - MassChallenge Switzerland, part of MassChallenge’s global network of zero-equity startup accelerators, today announced its 2020 cohort, selected from more than 1,000 applications and representing some of... |
| - | Grapheal raises EUR1.9 million from Novalis Biotech, BPI France and private investors, as well as non-dilutive grants |